Side effects Most common: nausea, vomiting, diarrhea, constipation, abdominal discomfort, headache, fatigue, injection-site reactions
The standard titration protocol Clinical trials used a gradual titration schedule, increasing the dose every four weeks to minimize gastrointestinal side effects
Type 2 diabetes: In a phase 3 clinical trial , tirzepatide lowered A1C levels by 2.34%2.40%, making it significantly more effective at lowering blood sugar levels than semaglutide and other GLP-1s
[27] Contraindications [edit] Tirzepatide is contraindicated for use in people with a personal or family history of medullary thyroid cancer and people with multiple endocrine neoplasia type 2
Afternoon snack: Protein shake (whey protein, 1 scoop in water)